Velphoro

(sucroferric oxyhydroxide)
Fresenius Kabi

Composition:

Available in chewable tablet with each contains 500 mg iron as sucroferric oxyhydroxide also known as a mixture of polynuclear iron(III)-oxyhydroxide, sucrose, and starches

Indication:

For the control of serum phosphorus levels in adult chronic kidney disease patients on haemodialysis or peritoneal dialysis

Drug information including formulation, indication, administration and/or presentation updated, registered or launched in Hong Kong within one year prior to the date written is regarded as new in The Pace.
The information in The Pace is provided as a courtesy service to our readers and is intended for medical professional reference only. Please peruse the latest local prescription information prior to prescription.